Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement

Reuters

2025/06/05

Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement

New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2541020470"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541020470\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541020470?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541020470","market":"nz","top_or_hot":-1,"title":"Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-05 20:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4192","symbol_name":"特殊消费者服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLbpfsFm:1","article_id":"2541020470","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541020470","pubTimestamp":1749126057,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. , a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4192":"特殊消费者服务","MRM":"MEDIROM Healthcare Technologies, Inc."},"translate_title":"Medirom Healthcare Technologies Inc.在满足最低投标价格要求后重新获得纳斯达克合规性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRM":0.9},"content_text":"Medirom Healthcare Technologies Inc. Regains NASDAQ Compliance After Meeting Minimum Bid Price Requirement\n    \n\n        New York, June 5, 2025 - MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a Japan-based holistic healthcare company, has announced that it has regained compliance with Nasdaq's minimum bid price requirement. The company had received a notification from Nasdaq on February 27, 2025, regarding its non-compliance with the rule, which mandates a minimum closing bid price of $1.00 per share for listed securities. MEDIROM was given until August 26, 2025, to meet this requirement. As of June 4, 2025, the company confirmed that its American Depositary Shares had maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20 to June 3, 2025. Consequently, Nasdaq has informed MEDIROM that it is now in compliance with the listing rule, closing the matter.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}